Phenazopyridine Hydrochloride Tablet
Product Images NDC 70518-3868

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Phenazopyridine Hydrochloride (NDC 70518-3868). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of a medication. The medication is a tablet containing 200 mg of Phenazopyridine HCI. The package contains 9 tablets. The medication is manufactured by Amneal Pharma, located in Ahmedabad, India. It is repackaged by RemedyRepack Inc., located in Indiana, PA. The medication is intended for prescription use only and should be kept out of reach of children. The specific expiration date and lot number are not available in the provided text. The directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F), with excursions permitted to 15.30°C (59-86°F) as per USP guidelines.*
FDA Label Image

Chem Structure (Phenazopyridine Hydrochloride Tablets Usp 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.